Business

Notification of Change of AGM Venue

Notification of Change of AGM Venue.

articleImmupharma PlcJune 2, 20203/company/immupharma-plc/news/notification-of-change-of-agm-venue
Notification of Change of AGM Venue

About this update from Immupharma Plc

[{"type":"text","content":"\n \n \n RNS Number : 5931O\n Immupharma PLC\n 02 June 2020\n  \n \n \n \n RNS: FOR IMMEDIATE RELEASE  2 June 2020\n \n \n  \n \n \n ImmuPharma PLC\n \n \n (\"ImmuPharma\" or the \"Company\")\n \n \n  \n \n \n Notification of Change of AGM Venue \n \n \n  \n \n \n ImmuPharma PLC (LSE:IMM), (Euronext Growth Brussels: ALIMM), the specialist drug discovery and development company announces that the Company's Annual General Meeting (AGM) confirmed for \n Thursday, 18 June 2020 @ 10.30am, will \n now be held at: 52 Grosvenor Garden, London SW1W 0AU. \n \n \n  \n \n \n The \n COVID-19 Guidance rules still apply, as set out in the announcement issued on 21 May 2020, (see Notes to Editors). \n Any shareholders attempting to gain access to the AGM will be excluded from the meeting on the ground of public safety.\n \n \n  \n \n \n This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014 (\"MAR\n \").\n \n \n \n \n \n \n  \n \n \n For further information please contact:\n \n \n  \n \n \n \n \n \n \n ImmuPharma PLC (\n \n www.immupharma.com\n \n )\n \n \n Tim McCarthy, Chairman\n \n \n \n \n + 44 (0) 207 152 4080\n \n \n \n \n \n \n Dimitri Dimitriou, Chief Executive Officer\n \n \n \n  \n \n \n \n \n \n Lisa Baderoon, Head of Investor Relations\n \n \n \n \n + 44 (0) 7721 413496\n \n \n  \n \n \n \n \n \n \n SPARK Advisory Partners Limited (NOMAD)\n \n \n Neil Baldwin\n \n \n  \n \n \n Stanford Capital Partners (Joint Broker)\n \n \n \n Patrick Claridge, John Howes\n \n \n  \n \n \n SI Capital (Joint Broker)\n \n \n Nick Emerson\n \n \n  \n \n \n \n \n +44 (0\n )\n 203 36\n 8 8974\n \n \n  \n \n \n  \n \n \n +44 (0) 203 815 8880\n \n \n  \n \n \n  \n \n \n +44 (0) 1483 413500\n \n \n  \n \n \n  \n \n \n \n \n \n \n 4Reliance (Euronext Growth Listing Sponsor)\n \n \n Jean-Charles Snoy\n \n \n  \n \n \n Degroof Petercam (Liquidity Provider)\n \n \n Erik De Clippel\n \n \n  \n \n \n Backstage Communication\n \n \n Olivier Duquaine\n \n \n Gunther De Backer\n \n \n \n \n +32 (0) 2 747 02 60\n \n \n  \n \n \n  \n \n \n +32 (0) 2 287 95 34\n \n \n  \n \n \n  \n \n \n  \n \n \n +32 (0) 477 504 784\n \n \n +32 (0) 475 903 909\n \n \n  \n \n \n \n \n \n  \n...

More updates from Immupharma Plc